[1]OrganicLetters,2006,vol.8,p.5829-5832
[1]CurrentPatentAssignee:CULLGENSHANGHAI-WO2021/239117,2021,A1Locationinpatent:Paragraph00554;00557;00558
100058-55-7
612-19-1
776-79-4
1077-58-3
2438-03-1
2438-04-2
152628-01-8 | Methyl 4-(butyrylamino)-3-methyl-5-nitrobenzoate | AA007JB6 | MFCD08062447
299921-01-0 | 1-(Methylsulfonyl)indolin-5-amine | AA007JT4 | MFCD01319362
28447-17-8 | ETHYL 3-(3-PYRIDYL)ACRYLATE | AA007KIN | MFCD02177443
27386-01-2 | 5-Methylamino-[1,3,4]thiadiazole-2-thiol | AA007L2B | MFCD00089421
13743-09-4 | 2-Methyl-5-phenyl-1,3-thiazole-4-carboxylic acid | AA007LHI | MFCD04178838
134526-69-5 | (R)-tert-Butyl 2-formylpiperidine-1-carboxylate | AA007M30 | MFCD06738714
26848-40-8 | 3-Hydroxy-n-(2-oxo-2,3-dihydro-1h-benzo[d]imidazol-5-yl)-2-naphthamide | AA007MIC | MFCD00388332
13602-11-4 | Methyl 6-methylpyridine-2-carboxylate | AA007MZM | MFCD06203670
25877-49-0 | 4-(5-Methyl-1,3,4-oxadiazol-2-yl)aniline | AA007NHB | MFCD01186079
13149-00-3 | Cis-1,2-cyclohexanedicarboxylic anhydride | AA007O2F | MFCD00005926